Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörn Wulf

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Medizinische Physik|February 11, 2003
Extracranial stereotactic radiotherapy: evaluation of PTV coverage and dose conformityUlrich Hädinger, Wibke Thiele, Jörn Wulf
Oncology Reports|October 5, 2007
Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapyDirk Vordermark, Andrea Lackenbauer, Jörn Wulf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 2, 2004
Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertionsJörn Wulf, Karoline Popp, Ulrich Oppitz, et al.
Zeitschrift Fur Medizinische Physik|August 25, 2004
A table top suited for CT and radiotherapyKlaus Bratengeier, Walter Baur, Kurt Baier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2004
Stereotactic boost irradiation for targets in the abdomen and pelvisJörn Wulf, Ulrich Hädinger, Ulrich Oppitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2003
Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liverJörn Wulf, Ulrich Hädinger, Ulrich Oppitz, et al.
Medical Physics|December 24, 2005
Target motion measurement without implanted markers and its validation by comparison with manually obtained dataLucia Vences, Jörn Wulf, Dirk Vordermark, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
How can we further improve radiotherapy for stage-III non-small-cell lung cancer?Gabriele K Beckmann, Oliver Kölbl, Thomas Krieger, et al.
Frontiers of Radiation Therapy and Oncology|December 4, 2009
Stereotactic body radiation therapy for early non-small cell lung cancerFrank Zimmermann, Jörn Wulf, Ingmar Lax, et al.
Acta Oncologica (Stockholm, Sweden)|August 30, 2006
3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life surveyDirk Vordermark, Jörn Wulf, Klaus Markert, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Medizinische Physik|February 11, 2003
Extracranial stereotactic radiotherapy: evaluation of PTV coverage and dose conformityUlrich Hädinger, Wibke Thiele, Jörn Wulf
Oncology Reports|October 5, 2007
Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapyDirk Vordermark, Andrea Lackenbauer, Jörn Wulf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 2, 2004
Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertionsJörn Wulf, Karoline Popp, Ulrich Oppitz, et al.
Zeitschrift Fur Medizinische Physik|August 25, 2004
A table top suited for CT and radiotherapyKlaus Bratengeier, Walter Baur, Kurt Baier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2004
Stereotactic boost irradiation for targets in the abdomen and pelvisJörn Wulf, Ulrich Hädinger, Ulrich Oppitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2003
Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liverJörn Wulf, Ulrich Hädinger, Ulrich Oppitz, et al.
Medical Physics|December 24, 2005
Target motion measurement without implanted markers and its validation by comparison with manually obtained dataLucia Vences, Jörn Wulf, Dirk Vordermark, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
How can we further improve radiotherapy for stage-III non-small-cell lung cancer?Gabriele K Beckmann, Oliver Kölbl, Thomas Krieger, et al.
Frontiers of Radiation Therapy and Oncology|December 4, 2009
Stereotactic body radiation therapy for early non-small cell lung cancerFrank Zimmermann, Jörn Wulf, Ingmar Lax, et al.
Acta Oncologica (Stockholm, Sweden)|August 30, 2006
3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life surveyDirk Vordermark, Jörn Wulf, Klaus Markert, et al.
Pageof 2